Adult 1 Anti-HIV Agents 1 Article 1 CD4 lymphocyte count 1 Cost-Benefit Analysis 1 Drug Combinations 1 HIV 1 HIV Infections 1 Heterocyclic Compounds, 3-Ring Human immunodeficiency virus 1 infection 1 Human immunodeficiency virus infection 1 Humans 1 Markov state model 1 Rilpivirine 1 Taiwan 1 abacavir plus dolutegravir plus lamivudine 1 adult 1 anti human immunodeficiency virus agent 1 cardiovascular disease 1 chronic kidney failure 1 clinical outcome 1 cobicistat plus elvitegravir plus emtricitabine plus tenofovir alafenamide 1 cost benefit analysis 1 cost control 1 cost effectiveness analysis 1 cost-effectiveness 1 data base 1 decision tree 1 dolutegravir 1 dolutegravir plus rilpivirine 1